Stress Hyperglycemia. Potential Role of Incretin Analogs

Hospital Universitari Son Dureta60 enrolled

Overview

This is a prospective observational study to examine the levels of glucoregulatory hormones, with special focus on incretins levels, in critically ill patients with stress hyperglycemia.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Hyperglycemia Critical Illness

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age \> 18 years * Emergent ICU admission * Written informed consent from patient or relative. Exclusion Criteria: * Previously known type I or type II diabetes. * Patients who received insulin or oral antidiabetic agents before ICU admission. * Malignancies. * Scheduled surgery * Patients receiving enteral or parenteral nutrition. * Inability to obtain informed consent.

Locations (1)

Hospital Universitari Son Dureta. Intensive Care Unit

Palma de Mallorca, Balearic Islands, Spain

Outcomes

Primary Outcomes

Incretins plasmatic levels

28 days and ICU mortality

Time frame: 28 days

Secondary Outcomes

glucagon

28 days and ICU mortality

Time frame: 28 days

insulin

28 days and ICU mortality

Time frame: 28 days

cortisol

28 days and ICU mortality

Time frame: 28 days

HOMA index

28 days and ICU mortality

Time frame: 28 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.